The Common Warts Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for common warts has witnessed significant growth in the recent past. It is projected to increase from $2.13 billion in 2024 to $2.26 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%.
The market size for common warts is predicted to reach $2.83 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.8%.
Download Your Free Sample of the 2025 Common Warts Market Report and Uncover Key Trends Now!The key drivers in the common warts market are:
• Rising geriatric population
• Growing prevalence of viral infections
• Increased adoption of advanced dermatological therapies
• Growing demand for personalized treatments
The common warts market covered in this report is segmented –
1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications
2) By Patient Demographics: Children, Adults, Elderly
3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage
4) By End User: Hospitals, Dermatology Clinics, Home Care
Subsegments:
1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy
2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO
2) Laser Therapy
3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation
4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy
The key trends in the common warts market are:
• Future common warts market trends include advancements in dermatological treatments.
• The market will be shaped by the expansion of healthcare infrastructure.
• Technological advancements in wart removal treatments play a significant role in the market's future.
• There is a growing shift towards minimally invasive treatments.
Major players in the common warts market are:
• AbbVie Inc.
• GlaxoSmithKline plc
• Sun Pharmaceutical Industries Limited
• Perrigo Company plc
• Holland & Barrett International Limited
• Prestige Consumer Healthcare Inc.
• Maruho Co. Ltd.
• Novan Inc.
• X4 Pharmaceuticals Inc.
• Aclaris Therapeutics Inc.
• Verrica Pharmaceuticals Inc.
• RXi Pharmaceuticals Corporation
• Scholl’s Wellness Company
• Nielsen BioSciences Inc.
• Cassiopea S.p.A.
• Orgenesis Inc.
• KinoPharma Inc.
• Naturasil
• Veradermics Inc.
• KinoPharma Co. Ltd.
North America was the largest region in the common warts market in 2024